**Detailed Summary of the Nordion International Inc./Theratronics International Limited Shares Order, 1988**

---

### **1. Legal Basis and Authority**

The Order is issued under the **Financial Administration Act (S.C. 1984, c. 31, s. 11)**, specifically pursuant to:

- **Paragraph 101(1)(b)**: Authorizes the Governor in Council to make orders for the sale or disposition of shares held by a Crown corporation, where it is determined that such a transaction is in the public interest.
- **Paragraph 101(1)(d)**: Enables the Governor in Council to authorize the acquisition of shares by a Crown corporation, where the transaction is deemed appropriate and in the national interest.
- **Paragraph 108(2)(b)**: Provides authority for the transfer of shares between Crown corporations, particularly when such transfers are intended to optimize public investment, align with strategic objectives, or support economic development.

The Governor in Council acted on the **recommendation of**:
- The **President of the Queen’s Privy Council for Canada**,
- The **Minister of Energy, Mines and Resources**, and
- The **Treasury Board**.

This reflects a collaborative, government-level decision-making process involving key departments responsible for energy, economic development, and financial oversight.

---

### **2. Purpose of the Order**

The primary objective of this Order is to **facilitate the transfer of ownership** of two Canadian-owned companies — **Nordion International Inc.** and **Theratronics International Limited** — from **Atomic Energy of Canada Limited (AECL)** to **Canada Development Investment Corporation (CDIC)**.

This transfer is not a routine corporate transaction but a strategic reallocation of assets within the Canadian Crown corporation framework, designed to:
- Improve the efficiency and effectiveness of public investment,
- Align corporate responsibilities with broader economic and industrial development goals,
- Ensure that assets with strong commercial and technological value are managed by entities best positioned to leverage them for national benefit.

---

### **3. Key Provisions of the Order**

#### **(a) Authorization to Sell/Dispose of Shares**
- **Atomic Energy of Canada Limited (AECL)** is authorized to:
  - **Sell or otherwise dispose of all common shares** of:
    - **Nordion International Inc.**
    - **Theratronics International Limited**
  - The disposition is to be made **to Canada Development Investment Corporation (CDIC)**.

> *Note:* The term “sell or otherwise dispose” includes options such as transfer, assignment, or any other form of transfer of ownership, allowing flexibility in the transaction structure.

#### **(b) Authorization to Acquire Shares**
- **Canada Development Investment Corporation (CDIC)** is authorized to:
  - **Acquire from AECL all common shares** of:
    - **Nordion International Inc.**
    - **Theratronics International Limited**

> This ensures that CDIC has the legal standing and authority to complete the acquisition without needing further legislative approval.

---

### **4. Scope and Effect**

- The Order applies to **all common shares** of both companies, meaning full ownership is being transferred.
- The transaction is **non-contingent** — once the Order is in force, AECL and CDIC are authorized to proceed with the transfer.
- The Order does **not** require further approval from Parliament or the public, as it operates under delegated authority under the Financial Administration Act.

---

### **5. Context and Strategic Rationale**

- **Atomic Energy of Canada Limited (AECL)** was historically involved in nuclear energy research, development, and technology. Over time, it began to divest non-core assets to focus on its primary mission in nuclear energy and safety.
- **Nordion International Inc.** and **Theratronics International Limited** are key companies in the **health technology sector**:
  - **Nordion** specializes in **radioisotopes and radiation therapy technologies**, including medical isotopes used in diagnostics and treatment.
  - **Theratronics** is a leader in **radiation therapy equipment**, particularly in the development and manufacturing of linear accelerators used in cancer treatment.
- By transferring these assets to **CDIC**, a Crown corporation focused on **economic development and investment in private sector enterprises**, the government aims to:
  - Enhance the commercial viability and innovation capacity of these companies,
  - Support the growth of Canada’s healthcare technology sector,
  - Promote public-private partnerships in medical technology,
  - Strengthen Canada’s competitiveness in global health and medical device markets.

---

### **6. Legal Citation and Title**

- The Order is formally titled:  
  **"The Nordion International Inc./Theratronics International Limited Shares Order, 1988"**
- It may be cited as such in legal and administrative references.

---

### **7. Significance and Implications**

- This Order represents a **strategic shift in the governance and portfolio management** of Crown corporations.
- It reflects a broader trend in Canadian public policy to **restructure Crown assets** to better align with market dynamics and national priorities.
- It underscores the government’s commitment to **technology transfer and public investment in health innovation**.
- The transaction likely paved the way for increased private-sector growth and R&D in Canada’s medical technology industry.

---

### **Conclusion**

The **Nordion International Inc./Theratronics International Limited Shares Order, 1988** is a legally binding instrument that authorizes the full transfer of ownership of two major medical technology companies from Atomic Energy of Canada Limited to Canada Development Investment Corporation. This transfer was made under the Financial Administration Act, based on strategic recommendations from key government officials, and reflects a deliberate effort to optimize public investment in health technologies. The Order ensures that these valuable assets are managed by an entity with a focus on economic development and commercial growth, ultimately contributing to Canada’s long-term competitiveness in the global healthcare sector.

--- 

*Note: This summary is based solely on the provided text and does not include external historical or financial data.*